{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:10:18Z","timestamp":1784765418694,"version":"3.55.0"},"reference-count":22,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.5551\/jat.63660","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T22:09:41Z","timestamp":1662415781000},"page":"675-683","source":"Crossref","is-referenced-by-count":5,"title":["Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com"],"prefix":"10.5551","volume":"30","author":[{"given":"Haruhiko","family":"Hoshino","sequence":"first","affiliation":[{"name":"Department of Neurology, Tokyo Saiseikai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Omae","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ichinomiya Nishi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[{"name":"Headquarters of the Iseikai Medical Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Clinical Epidemiology, University of Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Carcel C, Woodward M, Wang X, Bushnell C and Sandset EC: Sex matters in stroke: A review of recent evidence on the differences between women and men. Front Neuroendocrinol, 2020; 59: 100870","DOI":"10.1016\/j.yfrne.2020.100870"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Appelros P, Stegmayr B and Ter\u00e9nt A: Sex Differences in Stroke Epidemiology: A systematic review. Stroke, 2009; 40: 1082-1090","DOI":"10.1161\/STROKEAHA.108.540781"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Phan HT, Reeves MJ, Blizzard CL, Thrift AG, Cadilhac DA, Sturm J, Otahal P, Rothwell P, Bejot Y, Cabral NL, Appelros P, K\u00f5rv J, Vibo R, Minelli C and Gall SL: Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta-Analysis of Individual Participant Data. J Am Heart Assoc, 2019; 8: e010235","DOI":"10.1161\/JAHA.118.010235"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Math M, Meldrum HE and for the North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med, 1998; 339: 1415-1425","DOI":"10.1056\/NEJM199811123392002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC, Jr., Turan TN and Williams LS: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke, 2021; 52: e364-e467","DOI":"10.1161\/STR.0000000000000375"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH and Buring JE: A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women. N Engl J Med, 2005; 352: 1293-1304","DOI":"10.1056\/NEJMoa050613"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G and Brown DL: Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials. JAMA, 2006; 295: 306-313","DOI":"10.1001\/jama.295.3.306"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Antithrombotic Trialists\u2019 (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC and Zanchetti A: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 2009; 373: 1849-1860","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Caso V, Santalucia P, Acciarresi M, Pezzella FR and Paciaroni M: Antiplatelet treatment in primary and secondary stroke prevention in women. Eur J Intern Med, 2012; 23: 580-585","DOI":"10.1016\/j.ejim.2012.04.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Gotoh F, Tohge H, Hirai S, Terashi A, Fukuuchi Y, Otomo E, Shinohara Y, Itoh E, Matsuda T, Sawada T, Yamaguchi T, Nishimaru K and Ohashi Y: Cilostazol Stroke Prevention Study: A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction. J Stroke Cerebrovasc Dis, 2000; 9: 147-157","DOI":"10.1053\/jscd.2000.7216"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C and for the CSPS2 group: Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol, 2010; 9: 959-968","DOI":"10.1016\/S1474-4422(10)70198-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Goto S, Isomura T, Matsumoto M, Terayama Y, Tomimoto H, Tominaga T, Yasuda S, Kumagai N and CSPS.com Trial Investigators: Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol, 2019; 18: 539-548","DOI":"10.1016\/S1474-4422(19)30148-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Toyoda K, Uchiyama S, Hoshino H, Kimura K, Origasa H, Naritomi H, Minematsu K, Yamaguchi T and for the CSPS.com Study Investigators: Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial. Int J Stroke, 2015; 10: 253-258","DOI":"10.1111\/ijs.12420"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) The Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med, 1978; 299: 53-59","DOI":"10.1056\/NEJM197807132990201"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Antiplatelet Trialists\u2019 Collaboration: Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 1994; 308: 81-106","DOI":"10.1136\/bmj.308.6921.81"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996; 348: 1329-1339","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) SPS3 Investigators; Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS and Pearce LA: Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke. N Engl J Med, 2012; 367: 817-825","DOI":"10.1056\/NEJMoa1204133"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ and for the CHARISMA Investigators: Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med, 2006; 354: 1706-1717","DOI":"10.1056\/NEJMoa060989"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ and on behalf of the MATCH investigators: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004; 364: 331-337","DOI":"10.1016\/S0140-6736(04)16721-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW and for the PRoFESS Study Group: Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke. N Engl J Med, 2008; 359: 1238-1251","DOI":"10.1056\/NEJMoa0805002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shinohara Y and Huang Y: Cilostazol For Men, But Aspirin For Women In Stroke Prevention For Patients With Cerebral Infarction - Pooled Analysis Of CSPS 2 And CASISP. Stroke, 2012; 43: A2455","DOI":"10.1161\/str.43.suppl_1.A2455"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Wang J, Bingaman S and Huxley VH: Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases. Am J Physiol Heart Circ Physiol, 2010; 298: H1146-1154","DOI":"10.1152\/ajpheart.00252.2009"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/6\/30_63660\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T04:33:28Z","timestamp":1685766808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/6\/30_63660\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63660","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"article-number":"63660"}}